Antibody Drug Conjugate Market contains market size and forecasts of Antibody Drug Conjugate in global, including the following market information:
- Global Antibody Drug Conjugate Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Antibody Drug Conjugate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antibody Drug Conjugate companies in 2021 (%)
The global Antibody Drug Conjugate market was valued at 1746 million in 2021 and is projected to reach US$ 2803.7 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adcetris Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibody Drug Conjugate include Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, Pfizer, Celldex Therapeutics, Millennium Pharmaceuticals, Bayer HealthCare and Mersana Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Drug Conjugate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibody Drug Conjugate Market Segment Percentages, by Type, 2021 (%)
Global Antibody Drug Conjugate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibody Drug Conjugate Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Pharmaceutical Company
- Research Institutions
Global Antibody Drug Conjugate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibody Drug Conjugate Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antibody Drug Conjugate revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Antibody Drug Conjugate revenues share in global market, 2021 (%)
- Key companies Antibody Drug Conjugate sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Antibody Drug Conjugate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Seattle Genetics/Takeda
- Roche
- ImmunoGen
- Immunomedics
- Pfizer
- Celldex Therapeutics
- Millennium Pharmaceuticals
- Bayer HealthCare
- Mersana Therapeutics
- Heidelberg Pharma
- Oxford BioTherapeutics
- Takeda Pharmaceutical Company Limited